JW (Cayman) Therapeutics Co. Ltd
OTC: JWCTF0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Min Liu
- Employees
- 281
- Headquarters
- Shanghai, China
- IPO year
- 2021
- Market cap
- $98.9M
- Website
- https://www.jwtherapeutics.com
Loading JWCTF…
Loading profile data…Frequently asked questions about JWCTF
What does JW (Cayman) Therapeutics Co. Ltd (JWCTF) do?
JW (Cayman) Therapeutics Co. Ltd is a biopharmaceutical entity currently in the clinical development phase, dedicated to the discovery, manufacturing, and commercialization of advanced cell-based immunotherapeutic solutions. Its core mission is to combat both hematological cancers (blood cancers) and various solid tumors. The company's innovativ...
Where does JWCTF trade?
JW (Cayman) Therapeutics Co. Ltd (JWCTF) trades on the Other OTC.
What sector is JWCTF in?
JW (Cayman) Therapeutics Co. Ltd (JWCTF) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of JW (Cayman) Therapeutics Co. Ltd?
Min Liu is the chief executive officer of JW (Cayman) Therapeutics Co. Ltd (JWCTF).
Where is JW (Cayman) Therapeutics Co. Ltd headquartered?
JW (Cayman) Therapeutics Co. Ltd is headquartered in China.
Does JWCTF pay a dividend?
JW (Cayman) Therapeutics Co. Ltd (JWCTF) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did JWCTF go public?
JW (Cayman) Therapeutics Co. Ltd (JWCTF) completed its initial public offering in 2021.